Remove Communication Remove HIPAA Remove Labelling
article thumbnail

Pharmaceutical Marketing in 2025: Trends, Tech, and Targeting That Matter Most

Pharma Marketing Network

As industry leaders adapt to digital-first communication and omnichannel engagement, the need for smart, scalable, and strategic marketing tactics is more urgent than ever. As automation becomes smarter, ensuring HIPAA and GDPR compliance remains critical. However, marketers must balance innovation with privacy.

HIPAA 52
article thumbnail

How Has Social Media Advertising Changed in Pharma

Pharma Marketing Network

The shift is largely due to changes in user behavior, regulatory clarity, and the demand for more personalized, real-time communication. The emergence of HIPAA-compliant targeting technologies, HCP-specific segments, and improved analytics has made social platforms not just viable but essential for pharmaceutical marketing.

HIPAA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Email Marketing Campaigns for Pharma: Boost Engagement & Compliance

Pharma Marketing Network

Regulatory-Friendly Communication : Unlike social media ads, emails offer controlled messaging that aligns with compliance regulations. Challenges in Pharma Email Marketing Pharma brands face unique barriers that other industries dont , such as: Strict compliance regulations (FDA, GDPR, HIPAA) that limit messaging.

HIPAA 72
article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

As noted in our previous communications, while the NHC would prefer a more traditional Notice and Comment rulemaking opportunity that would ensure the Agency directly responds to stakeholder feedback, we welcome this opportunity to express our reactions to CMS’ thinking on the negotiation program.